Global Pharmacogenomics Technology (Theranostics & CDx) Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Pharmacogenomics Technology (Theranostics & CDx) will have significant change from previous year. According to our latest study, the global Pharmacogenomics Technology (Theranostics & CDx) market size is USD million in 2022 from USD 9383.3 million in 2021, with a change of % between 2021 and 2022. The global Pharmacogenomics Technology (Theranostics & CDx) market size will reach USD 25340 million in 2028, growing at a CAGR of 15.2% over the analysis period.
The United States Pharmacogenomics Technology (Theranostics & CDx) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pharmacogenomics Technology (Theranostics & CDx) market, reaching US$ million by the year 2028. As for the Europe Pharmacogenomics Technology (Theranostics & CDx) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pharmacogenomics Technology (Theranostics & CDx) players cover Illumina, Roche, Agilent, and Abbott, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmacogenomics Technology (Theranostics & CDx) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Instrument
Reagents and Consumables
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Tumor
Diabetes
Mental Diseases
Cardiovascular Diseases
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Illumina
Roche
Agilent
Abbott
Thermofisher
Qiagen
Guardant Health
MGI Tech Co., Ltd.
Amoydx Biology
Genomics
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmacogenomics Technology (Theranostics & CDx) Market Size 2017-2028
2.1.2 Pharmacogenomics Technology (Theranostics & CDx) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Pharmacogenomics Technology (Theranostics & CDx) Segment by Type
2.2.1 Instrument
2.2.2 Reagents and Consumables
2.2.3 Others
2.3 Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type
2.3.1 Pharmacogenomics Technology (Theranostics & CDx) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2017-2022)
2.4 Pharmacogenomics Technology (Theranostics & CDx) Segment by Application
2.4.1 Tumor
2.4.2 Diabetes
2.4.3 Mental Diseases
2.4.4 Cardiovascular Diseases
2.4.5 Others
2.5 Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application
2.5.1 Pharmacogenomics Technology (Theranostics & CDx) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2017-2022)
3 Pharmacogenomics Technology (Theranostics & CDx) Market Size by Player
3.1 Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Players
3.1.1 Global Pharmacogenomics Technology (Theranostics & CDx) Revenue by Players (2020-2022)
3.1.2 Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Players (2020-2022)
3.2 Global Pharmacogenomics Technology (Theranostics & CDx) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Pharmacogenomics Technology (Theranostics & CDx) by Regions
4.1 Pharmacogenomics Technology (Theranostics & CDx) Market Size by Regions (2017-2022)
4.2 Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth (2017-2022)
4.3 APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth (2017-2022)
4.4 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth (2017-2022)
4.5 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2017-2022)
5.2 Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022)
5.3 Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2017-2022)
6.2 APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022)
6.3 APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Pharmacogenomics Technology (Theranostics & CDx) by Country (2017-2022)
7.2 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022)
7.3 Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) by Region (2017-2022)
8.2 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022)
8.3 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.1 Global Pharmacogenomics Technology (Theranostics & CDx) Forecast by Regions (2023-2028)
10.1.1 Global Pharmacogenomics Technology (Theranostics & CDx) Forecast by Regions (2023-2028)
10.1.2 Americas Pharmacogenomics Technology (Theranostics & CDx) Forecast
10.1.3 APAC Pharmacogenomics Technology (Theranostics & CDx) Forecast
10.1.4 Europe Pharmacogenomics Technology (Theranostics & CDx) Forecast
10.1.5 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Forecast
10.2 Americas Pharmacogenomics Technology (Theranostics & CDx) Forecast by Country (2023-2028)
10.2.1 United States Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.2.2 Canada Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.2.3 Mexico Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.2.4 Brazil Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.3 APAC Pharmacogenomics Technology (Theranostics & CDx) Forecast by Region (2023-2028)
10.3.1 China Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.3.2 Japan Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.3.3 Korea Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.3.4 Southeast Asia Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.3.5 India Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.3.6 Australia Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.4 Europe Pharmacogenomics Technology (Theranostics & CDx) Forecast by Country (2023-2028)
10.4.1 Germany Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.4.2 France Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.4.3 UK Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.4.4 Italy Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.4.5 Russia Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.5 Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Forecast by Region (2023-2028)
10.5.1 Egypt Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.5.2 South Africa Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.5.3 Israel Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.5.4 Turkey Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.5.5 GCC Countries Pharmacogenomics Technology (Theranostics & CDx) Market Forecast
10.6 Global Pharmacogenomics Technology (Theranostics & CDx) Forecast by Type (2023-2028)
10.7 Global Pharmacogenomics Technology (Theranostics & CDx) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina Pharmacogenomics Technology (Theranostics & CDx) Product Offered
11.1.3 Illumina Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Roche
11.2.1 Roche Company Information
11.2.2 Roche Pharmacogenomics Technology (Theranostics & CDx) Product Offered
11.2.3 Roche Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Roche Main Business Overview
11.2.5 Roche Latest Developments
11.3 Agilent
11.3.1 Agilent Company Information
11.3.2 Agilent Pharmacogenomics Technology (Theranostics & CDx) Product Offered
11.3.3 Agilent Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Agilent Main Business Overview
11.3.5 Agilent Latest Developments
11.4 Abbott
11.4.1 Abbott Company Information
11.4.2 Abbott Pharmacogenomics Technology (Theranostics & CDx) Product Offered
11.4.3 Abbott Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Abbott Main Business Overview
11.4.5 Abbott Latest Developments
11.5 Thermofisher
11.5.1 Thermofisher Company Information
11.5.2 Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Product Offered
11.5.3 Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Thermofisher Main Business Overview
11.5.5 Thermofisher Latest Developments
11.6 Qiagen
11.6.1 Qiagen Company Information
11.6.2 Qiagen Pharmacogenomics Technology (Theranostics & CDx) Product Offered
11.6.3 Qiagen Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Qiagen Main Business Overview
11.6.5 Qiagen Latest Developments
11.7 Guardant Health
11.7.1 Guardant Health Company Information
11.7.2 Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Product Offered
11.7.3 Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Guardant Health Main Business Overview
11.7.5 Guardant Health Latest Developments
11.8 MGI Tech Co., Ltd.
11.8.1 MGI Tech Co., Ltd. Company Information
11.8.2 MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Product Offered
11.8.3 MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 MGI Tech Co., Ltd. Main Business Overview
11.8.5 MGI Tech Co., Ltd. Latest Developments
11.9 Amoydx Biology
11.9.1 Amoydx Biology Company Information
11.9.2 Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Product Offered
11.9.3 Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Amoydx Biology Main Business Overview
11.9.5 Amoydx Biology Latest Developments
11.10 Genomics
11.10.1 Genomics Company Information
11.10.2 Genomics Pharmacogenomics Technology (Theranostics & CDx) Product Offered
11.10.3 Genomics Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Genomics Main Business Overview
11.10.5 Genomics Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Pharmacogenomics Technology (Theranostics & CDx) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Instrument
Table 3. Major Players of Reagents and Consumables
Table 4. Major Players of Others
Table 5. Pharmacogenomics Technology (Theranostics & CDx) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2017-2022)
Table 8. Pharmacogenomics Technology (Theranostics & CDx) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2017-2022)
Table 11. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Player (2020-2022)
Table 13. Pharmacogenomics Technology (Theranostics & CDx) Key Players Head office and Products Offered
Table 14. Pharmacogenomics Technology (Theranostics & CDx) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Regions (2017-2022)
Table 19. Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Country (2017-2022)
Table 21. Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2017-2022)
Table 23. Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2017-2022)
Table 25. APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Region (2017-2022)
Table 27. APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2017-2022)
Table 29. APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2017-2022)
Table 31. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Country (2017-2022)
Table 33. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2017-2022)
Table 35. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Pharmacogenomics Technology (Theranostics & CDx)
Table 44. Key Market Challenges & Risks of Pharmacogenomics Technology (Theranostics & CDx)
Table 45. Key Industry Trends of Pharmacogenomics Technology (Theranostics & CDx)
Table 46. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share Forecast by Application (2023-2028)
Table 52. Illumina Details, Company Type, Pharmacogenomics Technology (Theranostics & CDx) Area Served and Its Competitors
Table 53. Illumina Pharmacogenomics Technology (Theranostics & CDx) Product Offered
Table 54. Illumina Pharmacogenomics Technology (Theranostics & CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Illumina Main Business
Table 56. Illumina Latest Developments
Table 57. Roche Details, Company Type, Pharmacogenomics Technology (Theranostics & CDx) Area Served and Its Competitors
Table 58. Roche Pharmacogenomics Technology (Theranostics & CDx) Product Offered
Table 59. Roche Main Business
Table 60. Roche Pharmacogenomics Technology (Theranostics & CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Roche Latest Developments
Table 62. Agilent Details, Company Type, Pharmacogenomics Technology (Theranostics & CDx) Area Served and Its Competitors
Table 63. Agilent Pharmacogenomics Technology (Theranostics & CDx) Product Offered
Table 64. Agilent Main Business
Table 65. Agilent Pharmacogenomics Technology (Theranostics & CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Agilent Latest Developments
Table 67. Abbott Details, Company Type, Pharmacogenomics Technology (Theranostics & CDx) Area Served and Its Competitors
Table 68. Abbott Pharmacogenomics Technology (Theranostics & CDx) Product Offered
Table 69. Abbott Main Business
Table 70. Abbott Pharmacogenomics Technology (Theranostics & CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Abbott Latest Developments
Table 72. Thermofisher Details, Company Type, Pharmacogenomics Technology (Theranostics & CDx) Area Served and Its Competitors
Table 73. Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Product Offered
Table 74. Thermofisher Main Business
Table 75. Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Thermofisher Latest Developments
Table 77. Qiagen Details, Company Type, Pharmacogenomics Technology (Theranostics & CDx) Area Served and Its Competitors
Table 78. Qiagen Pharmacogenomics Technology (Theranostics & CDx) Product Offered
Table 79. Qiagen Main Business
Table 80. Qiagen Pharmacogenomics Technology (Theranostics & CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Qiagen Latest Developments
Table 82. Guardant Health Details, Company Type, Pharmacogenomics Technology (Theranostics & CDx) Area Served and Its Competitors
Table 83. Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Product Offered
Table 84. Guardant Health Main Business
Table 85. Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Guardant Health Latest Developments
Table 87. MGI Tech Co., Ltd. Details, Company Type, Pharmacogenomics Technology (Theranostics & CDx) Area Served and Its Competitors
Table 88. MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Product Offered
Table 89. MGI Tech Co., Ltd. Main Business
Table 90. MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. MGI Tech Co., Ltd. Latest Developments
Table 92. Amoydx Biology Details, Company Type, Pharmacogenomics Technology (Theranostics & CDx) Area Served and Its Competitors
Table 93. Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Product Offered
Table 94. Amoydx Biology Main Business
Table 95. Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Amoydx Biology Latest Developments
Table 97. Genomics Details, Company Type, Pharmacogenomics Technology (Theranostics & CDx) Area Served and Its Competitors
Table 98. Genomics Pharmacogenomics Technology (Theranostics & CDx) Product Offered
Table 99. Genomics Main Business
Table 100. Genomics Pharmacogenomics Technology (Theranostics & CDx) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. Genomics Latest Developments
List of Figures
Figure 1. Pharmacogenomics Technology (Theranostics & CDx) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type in 2021
Figure 7. Pharmacogenomics Technology (Theranostics & CDx) in Tumor
Figure 8. Global Pharmacogenomics Technology (Theranostics & CDx) Market: Tumor (2017-2022) & ($ Millions)
Figure 9. Pharmacogenomics Technology (Theranostics & CDx) in Diabetes
Figure 10. Global Pharmacogenomics Technology (Theranostics & CDx) Market: Diabetes (2017-2022) & ($ Millions)
Figure 11. Pharmacogenomics Technology (Theranostics & CDx) in Mental Diseases
Figure 12. Global Pharmacogenomics Technology (Theranostics & CDx) Market: Mental Diseases (2017-2022) & ($ Millions)
Figure 13. Pharmacogenomics Technology (Theranostics & CDx) in Cardiovascular Diseases
Figure 14. Global Pharmacogenomics Technology (Theranostics & CDx) Market: Cardiovascular Diseases (2017-2022) & ($ Millions)
Figure 15. Pharmacogenomics Technology (Theranostics & CDx) in Others
Figure 16. Global Pharmacogenomics Technology (Theranostics & CDx) Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application in 2021
Figure 18. Global Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share by Player in 2021
Figure 19. Global Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size 2017-2022 ($ Millions)
Figure 21. APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size 2017-2022 ($ Millions)
Figure 22. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size 2017-2022 ($ Millions)
Figure 24. Americas Pharmacogenomics Technology (Theranostics & CDx) Value Market Share by Country in 2021
Figure 25. Americas Pharmacogenomics Technology (Theranostics & CDx) Consumption Market Share by Type in 2021
Figure 26. Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application in 2021
Figure 27. United States Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Region in 2021
Figure 32. APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application in 2021
Figure 33. China Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Country in 2021
Figure 40. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type in 2021
Figure 41. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application in 2021
Figure 42. Germany Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application in 2021
Figure 50. Egypt Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Pharmacogenomics Technology (Theranostics & CDx) Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 56. APAC Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 57. Europe Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 59. United States Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 60. Canada Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 63. China Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 64. Japan Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 65. Korea Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 67. India Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 68. Australia Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 69. Germany Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 70. France Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 71. UK Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 72. Italy Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 73. Russia Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 74. Spain Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 77. Israel Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Pharmacogenomics Technology (Theranostics & CDx) Market Size 2023-2028 ($ Millions)